尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Rowland Lloyd A, Conseiller Général. Insider active across 1 company, notably CytomX Therapeutics, Inc.. Aggregated, 11 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €25k. History available since 2 February 2022. The latest transaction was filed on 18 March 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
ROWLAND LLOYD A is Conseiller Général and General Counsel at CytomX Therapeutics, Inc. He has 11 filings in total, and in the recent filings we hold, the amounts are exclusively sales, totaling EUR 24636, between 2022-02-04 and 2025-03-20.